Meet the 2019 Laureates: Wiebke Arlt, MD, DSc, FRCP, FMedSci

Wiebke Arlt

Outstanding Clinical Investigator Award 

Wiebke Arlt is the William Withering Professor of Medicine at the University of Birmingham, UK, and an outstanding clinician scientist. Trained by Bruno Allolio, Walter Miller, and myself, she has made several seminal contributions to the field of endocrinology. Firstly, she identified the importance of dehydroepiandrosterone (DHEA) in women and in a landmark paper demonstrated the beneficial effects of DHEA replacement therapy in many women with primary and secondary adrenal insufficiency.

Secondly, utilizing novel human experiments of nature she described new forms of androgen excess arising from defects in critical co-factors for adrenal androgen secretion/ metabolism. P450 oxidoreductase deficiency is now established as the second commonest form of congenital adrenal hyperplasia and confirms an alternative pathway of dihydrotestosterone secretion in human fetal life. Similarly, disruption of DHEA sulfation by mutations in the PAPS synthase 2 donor enzyme results in hyperandrogenism and a PCOS-like phenotype. Thirdly, working with a team of investigators in Birmingham and building on the successful European Adrenal Network (ENS@T), Wiebke has pioneered the concept of urinary steroid metabolomics that is likely to be fundamental in the clinical diagnostic work up of patients with adrenal disorders and tumors. The diagnostic pattern of abnormalities seen in adrenocortical carcinoma is striking; Wiebke’s recent work has uncovered fascinating insight into the pluripotential nature of other adrenal adenomas such as Conn’s tumors.

She is an excellent communicator and a living example of the importance of internationalization for our endocrine community and the Endocrine Society.

Over and above these major contributions, Wiebke has furthered our understanding of, and defined outcomes for, patients with a variety of adrenal pathologies. She is an excellent communicator and a living example of the importance of internationalization for our endocrine community and the Endocrine Society.

Paul M. Stewart, MD, FRCP, FMedSci, executive dean and professor at the University of Leeds School of Medicine, Leeds, U.K.; associate editor, Journal of the Endocrine Society; 2017 International Excellence in Endocrinology Laureate Award recipient.

You may also like

  • Holly A. Ingraham, PhD, Receives FASEB Excellence in Science Lifetime Achievement Award

    Endocrine Society member Holly A. Ingraham, PhD, is the recipient of the FASEB Excellence in Science Lifetime Achievement Award. On April 8, the organization announced the winners of its 2024 Excellence in Science Awards, which highlight outstanding achievements by women in biological sciences who demonstrate not only excellence and innovation in their research fields, but…

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…

Find more in